Evidence map›Paper›PMID 39279121›Full record

ArticleCurrent medicinal chemistry2025

Features of Gene Regulation in Violation of the Inflammatory Response of Monocyte-like Cells Bearing Mitochondrial Mutations Associated with Atherosclerosis.

Alexander N Orekhov, Nikita G Nikiforov, Alexander D Zhuravlev, Svetlana S Verkhova, Andrey V Omelchenko, Daria D Borodko, Vasily N Sukhorukov, Vasily V Sinyov, Igor A Sobenin

Abstract read
In one paragraph

Article in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexander N OrekhovInstitute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia.
Nikita G NikiforovInstitute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia.
Alexander D ZhuravlevInstitute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia.
Svetlana S VerkhovaInstitute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia.
Andrey V OmelchenkoInstitute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia.
Daria D BorodkoInstitute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia.
Vasily N SukhorukovInstitute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia.
Vasily V SinyovNational Medical Research Center of Cardiology, 15a Academician Chazov Street, 121552, Moscow, Russia.
Igor A SobeninNational Medical Research Center of Cardiology, 15a Academician Chazov Street, 121552, Moscow, Russia.

Funding

Russian Science Foundation 23-45-00031
6 · The paper itself

Abstract

Аims: This research aimed to study the features of gene regulation of the inflammatory response in cells carrying mitochondrial mutations associated with atherosclerosis.

backgroundInflammation plays an important, if not decisive, role in the occurrence of atherosclerotic lesions and then accompanies it throughout its further development. Thus, atherogenesis is a chronic inflammatory process. Chronification of inflammation is a consequence of disruption of the normal inflammatory response at the cell level of the vascular wall.

objectivesIn this study, we used cytoplasmic hybrids or cybrids carrying atherosclerosis- associated mitochondrial mutations to study gene regulation of inflammatory response. The main goal of the study was to identify the key genes responsible for the impaired inflammatory response revealed for some cybrids.

methodsInflammatory stimulation of cybrids was induced with bacterial lipopolysaccharide, and assessed through secretion of pro-inflammatory cytokines CCL2, IL8, IL6, IL1b. A transcriptome analysis was performed to identify the key genes (master regulators) in the normal (tolerant) and intolerant response of cybrid cells.

resultsNormal inflammatory response after re-stimulation elicited a much smaller secretion of pro-inflammatory cytokines. In an intolerant response, the level of secretion upon re-stimulation was the same or even higher than after the first stimulation. Normal and intolerant responses differed significantly both in terms of the number of signaling pathways involved and qualitatively, since the signaling pathways for normal and intolerant responses are completely different. Master regulators controlling normal and intolerant inflammatory response were identified. For a normal response to the first inflammatory stimulation, no common master up-regulators and 3 master down-regulators were identified. The reverse situation was observed with the intolerant inflammatory response: 6 master up-regulators, and no master down regulators were identified. After the second inflammatory stimulation, no master regulator common to all studied cytokines was found. Thus, key genes involved in the development of intolerant inflammatory response have been identified. In addition, other key genes were identified that were initially associated with an intolerant inflammatory response and thus determine disorders of the inflammatory reaction leading to chronification of inflammation.

conclusionWe identified disturbances in gene associated with the development of intolerant immune response that may be relevant to atherosclerosis. Key genes responsible for the chronification of inflammation were discovered.

Indexed as

AtherosclerosisGene Expression RegulationInflammationMitochondriaMonocytesCytokinesHumansLipopolysaccharidesMutationCytokinesLipopolysaccharidesCybridcytokineinflammatory stimulationintolerant responsemaster regulatormitochondrial mutationssignaling pathwaytrained immunity.

Identifiers

PMID39279121
PMCPMC12376108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.